Experience of Risk-reducing Salpingo-oophorectomy for a BRCA1 Mutation Carrier and Establishment of a System Performing a Preventive Surgery for Hereditary Breast and Ovarian Cancer Syndrome in Japan: Our Challenges for the Future

Author： Hirasawa Akira   Masuda Kenta   Akahane Tomoko   Tsuruta Tomohiko   Banno Kouji   Makita Kazuya   Susumu Nobuyuki   Jinno Hiromitsu   Kitagawa Yuko   Sugano Kokichi   Kosaki Kenjiro   Aoki Daisuke  

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.5, 2013-05, pp. : 515-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

By Domchek Susan  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 195-203

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy

By Fakkert Ingrid   Jansen Liesbeth   Meijer Kees   Kok Theo   Oosterwijk Jan   Mourits Marian   Bock Geertruida  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy

By Tait David  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 101-102

Informa Healthcare

Access to resources Recommend Favorite

Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation

By Kim Dongwon   Kang Eunyoung   Hwang Euijun   Sun Young   Hwang Yoonsun   Yom Cha   Kim Kidong   No Jae   Kim Yong-Beom   Kim Sung-Won  

Familial Cancer, Vol. 12, Iss. 4, 2013-12 ,pp. : 621-628

Springer Publishing Company

Access to resources Recommend Favorite

Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer (Review)

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-03 ,pp. : 267-273

Science Publishers

Access to resources Recommend Favorite